|
SPAG5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.86520000000634E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
9.315800E-02 |
| Stage1-vs-Stage3 |
9.147800E-01 |
| Stage1-vs-Stage4 |
1.618640E-03 |
| Stage2-vs-Stage3 |
1.037430E-01 |
| Stage2-vs-Stage4 |
7.336200E-03 |
| Stage3-vs-Stage4 |
3.948400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.64983999999535E-05 |
| Normal-vs-Asian |
2.22266649529956E-12 |
| Caucasian-vs-AfricanAmerican |
9.543600E-01 |
| Caucasian-vs-Asian |
5.163800E-01 |
| AfricanAmerican-vs-Asian |
7.946200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
5.983600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.10536057873878E-12 |
| Normal-vs-Age(81-100Yrs) |
8.179800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.235400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.279900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.779600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.230410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.412600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.560400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.803800E-04 |
| Classical-VS-Follicular |
4.661300E-03 |
| Classical-VS-Other |
4.912800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.65458999999979E-05 |
| Tall-VS-Other |
2.576400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.020800E-01 |
| Follicular-VS-Normal |
2.55100052193313E-10 |
| Other-VS-Normal |
3.864300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
2.676100E-03 |
|
|
